21474db6cdf3a2fc…

Study
ID: NCT00074529681 bytesFirst seen Jun 12, 20261 collection

Fields

NameValue
briefSummaryAn investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.
completionDate2006-01
conditions["Alzheimer's Disease"]
enrollmentCount512
enrollmentTypeACTUAL
nctIdNCT00074529
phasePHASE2
sponsorIdmerck-sharp-dohme-llc
startDate2003-10
statusCOMPLETED
studyTypeINTERVENTIONAL
titleA Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease
urlhttps://clinicaltrials.gov/study/NCT00074529

Canonical JSON

{
  "id": "NCT00074529",
  "type": "Study",
  "data": {
    "briefSummary": "An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.",
    "completionDate": "2006-01",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 512,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00074529",
    "phase": "PHASE2",
    "sponsorId": "merck-sharp-dohme-llc",
    "startDate": "2003-10",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00074529"
  }
}

Appears in 1 collection

nih/clinical-trials1 version · Jun 12, 2026

Full hash:21474db6cdf3a2fcd129ee4a3ea74e7c593ca63bb911bceebb9620d6102a12ca